Combined treatment with chrysin and 1,2,3,4,6‐penta‐O‐galloyl‐β‐D‐glucose synergistically inhibits LRP6 and Skp2 activation in triple‐negative breast cancer and xenografts

Publisher: John Wiley & Sons Inc

E-ISSN: 1098-2744|54|12|1613-1625

ISSN: 0899-1987

Source: Molecular Carcinogenesis, Vol.54, Iss.12, 2015-12, pp. : 1613-1625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract